| scholarly article | Q13442814 |
| P50 | author | Iman Tahamtan | Q59160344 |
| P2093 | author name string | Pooneh Nikuei | |
| Abbas Ali Keshtkar | |||
| Nahid Davoodian | |||
| P2860 | cites work | Emerging new biomarkers of preeclampsia | Q38127554 |
| Differential expression of microRNAs in the placentae of Chinese patients with severe pre-eclampsia | Q38509337 | ||
| Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. | Q38516599 | ||
| Variations of microRNAs in human placentas and plasma from preeclamptic pregnancy | Q39012178 | ||
| The definition of severe and early-onset preeclampsia. Statements from the International Society for the Study of Hypertension in Pregnancy (ISSHP). | Q40804549 | ||
| Is serum placental growth factor more effective as a biomarker in predicting early onset preeclampsia in early second trimester than in first trimester of pregnancy? | Q44401617 | ||
| Can maternal serum placental growth factor estimation in early second trimester predict the occurrence of early onset preeclampsia and/or early onset intrauterine growth restriction? A prospective cohort study | Q45230594 | ||
| MicroRNA-376c impairs transforming growth factor-β and nodal signaling to promote trophoblast cell proliferation and invasion | Q46320867 | ||
| Differential expression of microRNA in peripheral blood mononuclear cells as specific biomarker for major depressive disorder patients | Q48217358 | ||
| Potential role of circulating microRNAs as early markers of preeclampsia. | Q51512360 | ||
| Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies. | Q54491050 | ||
| Detection and Characterization of Placental MicroRNAs in Maternal Plasma | Q58029285 | ||
| The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP | Q85446003 | ||
| Serum microRNAs are promising novel biomarkers | Q21144238 | ||
| MicroRNA-210: a unique and pleiotropic hypoxamir | Q24601095 | ||
| A brief overview of preeclampsia | Q27003730 | ||
| MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4 | Q28251320 | ||
| miR-210: More than a silent player in hypoxia | Q28306244 | ||
| Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation | Q29615706 | ||
| [The Strengthening the Reporting of Observational Studies in Epidemiology [STROBE] statement: guidelines for reporting observational studies]. | Q33329004 | ||
| Human placental microRNAs and preeclampsia | Q33581645 | ||
| Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia | Q33863973 | ||
| Placental microRNA expression in pregnancies complicated by preeclampsia | Q34150969 | ||
| Expression Profile of MicroRNAs and mRNAs in Human Placentas From Pregnancies Complicated by Preeclampsia and Preterm Labor | Q35930887 | ||
| Preeclampsia up-regulates angiogenesis-associated microRNA (i.e., miR-17, -20a, and -20b) that target ephrin-B2 and EPHB4 in human placenta | Q36069875 | ||
| Quantification of preeclampsia-related microRNAs in maternal serum | Q36321403 | ||
| Hypoxia-inducible miR-210 contributes to preeclampsia via targeting thrombospondin type I domain containing 7A. | Q36500746 | ||
| MicroRNAs in Human Placental Development and Pregnancy Complications | Q36790358 | ||
| Elevated levels of hypoxia-inducible microRNA-210 in pre-eclampsia: new insights into molecular mechanisms for the disease | Q37295740 | ||
| Prenatal Clinical Assessment of sFlt-1 (Soluble fms-like Tyrosine Kinase-1)/PlGF (Placental Growth Factor) Ratio as a Diagnostic Tool for Preeclampsia, Pregnancy-induced Hypertension, and Proteinuria | Q37395519 | ||
| Circulating microRNAs: Association with disease and potential use as biomarkers | Q37818867 | ||
| Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: a systematic review | Q37901092 | ||
| Role of microRNAs in kidney homeostasis and disease | Q37975142 | ||
| Diagnostic potential for miRNAs as biomarkers for pregnancy-specific diseases | Q38080397 | ||
| P433 | issue | 9 | |
| P921 | main subject | systematic review | Q1504425 |
| pre-eclampsia | Q61335 | ||
| biomarker | Q864574 | ||
| P304 | page(s) | e011920 | |
| P577 | publication date | 2016-09-28 | |
| P1433 | published in | BMJ Open | Q17003470 |
| P1476 | title | Predictive value of miR-210 as a novel biomarker for pre-eclampsia: a systematic review protocol | |
| P478 | volume | 6 |
| Q92592260 | Effects of Selenium Supplementation on Cardiometabolic Risk Factors, Inflammatory, and Antioxidant Markers: A Systematic Review and Meta-analysis Protocol |
| Q33778450 | Identification of key microRNAs and genes in preeclampsia by bioinformatics analysis |
| Q41049964 | MiR-210 and miR-155 as potential diagnostic markers for pre-eclampsia pregnancies |
| Q64970643 | Roles of miR-210 in the pathogenesis of pre-eclampsia. |
Search more.